Search Results

Vylor and Belgium-based Rainbow Crops Enter Strategic Partnership to Combine AI and Multiplex Gene Editing for Maize Complex Stress Tolerance Traits

Agricultural technology innovation company Vylor and Belgian agricultural biotechnology startup Rainbow Crops announced the establishment of a deep R&D collaboration. The two parties will deeply integrate Artificial intelligence (AI) algorithm-assisted design with high-throughput Multiplex gene editing technology, leveraging Rainbow Crops' proprietary Trait Foundry trait discovery and validation platform, focusing on abiotic environmental stresses such as heat damage, extreme drought, and waterlogging, to screen and validate highly climate-adaptive maize hybrid germplasm materials. The core process pipeline of this cross-border collaboration will combine AI-assisted trait prediction, multiplex multi-locus...

2026-09-24

Lower likelihood of restart for Belgium's Doel 3 and Tihange 2 reactors

According to a September 11 report by Le Soir, samples collected nearly two years ago from the reactor pressure vessels of Belgium's Doel 3 and Tihange 2 reactors indicate that the possibility of restarting these two nuclear reactors is extremely low. In the winter of 2024 to 2025, operator Engie successively took samples from the Doel 3 reactor pressure vessel and the Tihange 2 reactor pressure vessel. The sampling work was carried out at the request of the Belgian Federal Agency for Nuclear Control (FANC) and the Belgian National Agency for Radioactive Waste and Enriched Fissile Materials (NIRAS), which is responsible for radioactive waste management, with the aim of measuring in detail the radiation levels at different parts of the pressure vessels so as to classify and dispose of the related waste.

2026-09-13

GE HealthCare's Photonova Spectra Photon-Counting CT Receives CE Mark, to Be Commercialized in Countries Recognizing CE Marking

On August 31, GE HealthCare announced that its advanced photon-counting computed tomography (PCCT) system, Photonova Spectra, has received CE marking. The system utilizes GE HealthCare's proprietary Deep Silicon™ detector technology. This certification will expand the system's availability in countries and regions that recognize the CE mark and pave the way for its clinical use. According to reports, Photonova Spectra is designed to address the growing patient volumes and increasing diagnostic complexity faced by healthcare institutions today, aiming to provide clinicians with clearer and more timely imaging information. Leveraging deep silicon detector technology, the system can acquire spectral and spatial imaging information in each scan...

2026-09-01

Curium Acquires Belgium's Abscint, Expanding HER2-Targeted Gallium-68 PET Oncology Radiopharmaceutical Diagnostics Pipeline

On August 10, 2026, radiopharmaceutical company Curium announced the completion of its acquisition of Abscint SA, a Belgian clinical-stage radiopharmaceutical company. The transaction grants Curium global development, manufacturing, and commercialization rights to ABS-011, further expanding its oncology PET radiopharmaceutical diagnostics portfolio. ABS-011 is an investigational gallium-68-labeled positron emission tomography (PET) radiopharmaceutical diagnostic tracer targeting human epidermal growth factor receptor 2 (HER2). HER2 is an important biological target in multiple cancers, including breast cancer and gastric cancer. Based on available information, ABS-011 is designed to enable whole-body quantitative imaging of HER2 expression, and following further clinical development and regulatory approval, has the potential to provide more comprehensive HER2 status information for patient characterization and clinical assessment.

2026-08-11

GAO Report Urges DOE-EM to Learn from Canada, UK, France, and Belgium in Reshaping Nuclear Waste Cleanup Strategy

The U.S. Government Accountability Office (GAO) noted in a new report that countries such as Canada, France, and the United Kingdom have taken proactive measures in recent years to accelerate nuclear waste cleanup. The report recommends that the U.S. Department of Energy's Office of Environmental Management (DOE-EM) engage in strategic exchanges with these countries to identify and evaluate alternative approaches that could reduce risks, lower costs, or expedite cleanup activities. Currently, DOE-EM estimates its cleanup mission could cost between $641 billion and $840 billion and may not be completed until 2100. The report found that while DOE-EM has some level of exchange with other countries on nuclear cleanup, such exchanges are not strategic and lack proactive learning...

2026-08-04